Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH). (Q42194018)
scientific article
Language:
Current Data About Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH).
(P31) (Q13442814)
(P248)
(P698) 2618590
(P813) Wednesday, October 18, 2017

(P304) 183-187
(P248)
(P698) 2618590
(P813) Wednesday, October 18, 2017

(P478) 126
(P248)
(P698) 2618590
(P813) Wednesday, October 18, 2017

(P577) Sunday, January 1, 1989
(P248)
(P698) 2618590
(P813) Wednesday, October 18, 2017

(P921) (Q192423)
(P887)

(P1433) (Q27020379)
(P248)
(P698) 2618590
(P813) Wednesday, October 18, 2017

(P1476) "Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH)." (language: en)
(P248)
(P698) 2618590
(P813) Wednesday, October 18, 2017

(P2093) G J Birkmayer
(P1545) 1
(P248)
(P698) 2618590
(P813) Wednesday, October 18, 2017

W Birkmayer
(P1545) 2
(P248)
(P698) 2618590
(P813) Wednesday, October 18, 2017

other details
description scientific article

External Links
(P356) 10.1111/J.1600-0404.1989.TB01800.X
(P698) 2618590